English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech HealthCare & Pharma
万美集团推出M-care个人防护装备
May 27, 2020 06:00 HKT
Mainetti to launch M-care PPE Range
May 27, 2020 06:00 HKT
Novotech and Endpoints to present APAC Clinical Trial webinar series
May 26, 2020 19:00 HKT
ZALL Group Donates 1 Million Surgical Masks to Singapore Red Cross (SRC)
May 23, 2020 11:00 HKT
애질렉스 바이오랩스, 바이오코리아(BIO Korea) 2020에서 임상 시험 비용에 대한 세계 최대 규모 리베이트 등 호주의 강점 선보일 예정
May 21, 2020 09:00 HKT
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus
May 20, 2020 18:15 HKT
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020
May 20, 2020 16:00 HKT
經申辦方推選,Novotech 榮獲“CRO 領導力大獎”
May 20, 2020 11:00 HKT
经申办方推选,Novotech 荣获“CRO 领导力大奖”
May 20, 2020 11:00 HKT
COVID-19 Crisis: Aetna Expands NIPT Coverage for Young Pregnant Women
May 19, 2020 03:00 HKT
Cyber Company to Supply 50M Health "COVI-PASS(TM)"
May 08, 2020 14:30 HKT
商业化变现在即 开拓药业核心产品优势明显
May 08, 2020 10:12 HKT
商業化變現在即 開拓藥業核心產品優勢明顯
May 08, 2020 10:11 HKT
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study
Apr 29, 2020 21:00 HKT
노보텍의 코로나19 임상시험 클라이언트, 아시아태평양 지역의 새로운 패스트트랙 심의과정의 혜택을 누리다
Apr 28, 2020 19:00 HKT
Novotech COVID-19 臨床試驗客戶受益於亞太地區新的快速審批流程
Apr 28, 2020 19:00 HKT
Novotech COVID-19 临床试验客户受益于亚太地区新的快速审批流程
Apr 28, 2020 19:00 HKT
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
Apr 28, 2020 19:00 HKT
GeoMap Clinical Patient Recruitment Platform Now Guarantees Enrollment Numbers
Apr 28, 2020 15:00 HKT
华领医药宣布Dorzagliatin与恩格列净(一种SGLT-2抑制剂)联合用药临床研究的成功结果
Apr 27, 2020 09:53 HKT
<< Previous  Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: